MARÍA MAGDALENA
SALCEDO PLAZA
Profesora asociada de Ciencias de la Salud
Manuel Luís
Rodriguez Perálvarez
Publicaciones en las que colabora con Manuel Luís Rodriguez Perálvarez (13)
2024
-
The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis
Liver International, Vol. 44, Núm. 2, pp. 279-285
2022
-
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation
American Journal of Transplantation, Vol. 22, Núm. 6, pp. 1671-1682
-
Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019
Liver Transplantation, Vol. 28, Núm. 6, pp. 1039-1050
-
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study
Alimentary Pharmacology and Therapeutics, Vol. 56, Núm. 1, pp. 131-143
-
Noninvasive Prediction of Outcomes in Autoimmune Hepatitis–Related Cirrhosis
Hepatology Communications, Vol. 6, Núm. 6, pp. 1392-1402
2021
-
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2876-2884
-
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients
Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155
-
Modulating immunosuppression in liver transplant patients with COVID-19
Gut
-
Reply to: “Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients”
Journal of Hepatology
-
Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study
Digestive Diseases and Sciences, Vol. 66, Núm. 8, pp. 2826-2832
2020
-
Increased incidence of COVID-19 among liver transplant patients in Europe
Transplant International
-
Letter: unknown denominator and misleading conclusions in COVID-19
Alimentary Pharmacology and Therapeutics
2017
-
Real-world multicenter experience of immunosuppression minimization among 661 liver transplant recipients
Annals of Transplantation, Vol. 22, pp. 265-275